Results 81 to 90 of about 147,513 (305)

Proton Therapy in Uveal Melanoma

Background/Objectives: Uveal melanoma is the most common primary intraocular malignancy in adults. Treatment options for localized, early-stage disease include enucleation, brachytherapy, and proton beam therapy.
Choi, J. Isabelle, Yacoub, Irini, Chan, Adrian Wai, J. Isabelle Choi, Charles B. Simone, Chhabra, Arpit M., Haibo Lin, Irini Yacoub, Adrian Wai Chan, Arpit M. Chhabra, Lin, Haibo, Simone, Charles B.   +11 more
core   +1 more source

Clinical outcomes after international referral of uveal melanoma patients for proton therapy

, 2021
Simple Summary This study aims to assess cancer control and preservation of the eye and visual acuity after proton therapy abroad for eye melanoma. For this, medical files were reviewed of Dutch uveal melanoma patients who were treated in Switzerland ...
Sjoerd G. Van Duinen, Luyten, G.P.M., Schalenbourg, A., van den Berg, V., Horeweg, N., Duinen, S.G. van, Jan Hrbacek, Rasch, C.R.N., Rasch, CRN, Pors, L.J., Lennart J. Pors, Vincent van den Berg, Coen R. N. Rasch, Zografos, L., Ann Schalenbourg, Vu, THK, Pica, A., Luyten, GPM, Van Duinen, S.G., Gregorius P. M. Luyten, Jager, M.J., Marina Marinkovic, T. H. Khanh Vu, Femke P. Peters, Bleeker, J.C., Leonidas Zografos, Peters, F.P., Nanda Horeweg, Berg, V. van den, Alessia Pica, Martine J. Jager, Vu, T.H.K., Jaco C. Bleeker, Marinkovic, M., Hrbacek, J.   +34 more
core   +1 more source

Proton therapy

Biomedical Journal, 2015
Kuniaki Katsui, Tomoaki Okimoto, Susumu Kanazawa   +2 more
  +6 more sources

Respiratory-gated proton beam therapy for intrahepatic cholangiocarcinoma without fiducial markers

Radiation Oncology
Background Intrahepatic cholangiocarcinoma (ICC) is a challenging primary liver cancer with a poor prognosis, especially in unresectable cases. Traditional palliative irradiation is limited in reducing liver doses.
Akihito Okubo, Sae Matsumoto, Hiroyasu Tamamura, Yoshitaka Sato, Satoko Asahi, Hitoshi Tatebe, Kazutaka Yamamoto, Keiichiro Matsushita, Makoto Sasaki, Yoshikazu Maeda, Yuji Tameshige, Hajime Sunagozaka, Hiroyuki Aoyagi, Satoshi Shibata, Shigeyuki Takamatsu, Satoshi Kobayashi   +15 more
doaj   +1 more source

Inflammation Unchecked: Concurrent Kawasaki Disease and Stevens‐Johnson Syndrome in an 18‐Month‐Old Child

Arthritis Care &Research, EarlyView.
Catherine Deffendall, Jodi Backalar, Elizabeth Acevedo Zapata, Adriana Della Porta, Lorin Bibb, Tyler Reese, Charlotte M. Brown   +6 more
wiley   +1 more source

Bioorthogonal Photoactivation of 2‐Nitrobenzyl Caged Doxorubicin Anticancer Prodrugs on Gold Nanostars

Advanced Materials, EarlyView.
Bioorthogonal chemistry was applied to intracellularly photoactivate Doxorubicin (Dox) using gold nanostars (AuNSt) and near‐infrared (NIR) light. Two prodrugs were used: one photoactivatable, masked with 2‐nitrobenzyl carbamate (proDox1) and another photolabile, masked with 2‐nitrobenzyl diol (proDox2), which was attached to the AuNSt surface.
Juan José Esteve‐Moreno, Andrea Escudero, Oscar Ferreira Silvestre, José Manuel Terrés, Mónica Gorbe, Eva Garrido, Carlos Renero‐Lecuna, Judith Langer, María Alfonso, Javier Ibañez, Félix Sancenón, Roberto Cao‐Milán, Luis M. Liz‐Marzán, Alba García‐Fernández, Andy Hernández‐Montoto, Ramón Martínez‐Máñez   +15 more
wiley   +1 more source

Dexime: A Selectively Enzyme‐Degradable Hydrogel for Protein Therapeutic Release

Advanced Materials, EarlyView.
A dextrin‐oxime hydrogel (dexime) is produced using ketone or aldehyde modified dextrin and tetra‐oxyamine modified poly(ethylene glycol). The rheological and mechanical properties of dexime are tunable. Dexime is injectable, cytocompatible, hydrolytically stable, and selectively degradable by α‐amylase.
Quinton E. A. Sirianni, Nitzan Letko Khait, Adam Forman, Edward A. Armstrong, Karim Fouad, Molly S. Shoichet   +5 more
wiley   +1 more source

Proton Beam Therapy for Esophageal Cancer

, 2022
SIMPLE SUMMARY: Early-stage esophageal cancer is managed surgically, with the addition of radiotherapy for locally advanced disease. Current photon-based radiotherapy results in a high treatment-related complications, due to proximal organ involvement ...
Dee, Edward Christopher, Wo, Jennifer Y., Jennifer Y. Wo, Solidum, Jea Giezl N., Raniv D. Rojo, Rojo, Raniv D., Jea Giezl N. Solidum, Edward Christopher Dee   +7 more
core   +1 more source

Proton-counting radiography for proton therapy: a proof of principle using CMOS APS technology

, 2014
Despite the early recognition of the potential of proton imaging to assist proton therapy (Cormack 1963 J. Appl. Phys. 34 2722), the modality is still removed from clinical practice, with various approaches in development. For proton-counting radiography
Spyros Manolopoulos (17189305), Thalis Anaxagoras (17152918), Stuart Green (113477), Nigel Allinson (17152816), Michela Esposito (17157484), Jamie Nieto-Camero (17189302), Philip Evans (3482804), Gavin Poludniowski (3913423), David Parker (203986), Tony Price (17177902)   +9 more
core   +1 more source

Possible association of dose rate and the development of late visual toxicity for patients with intracranial tumours treated with pencil beam scanned proton therapy

Radiation Oncology
Background and purpose Rare but severe toxicities of the optic apparatus have been observed after treatment of intracranial tumours with proton therapy.
Arturs Meijers, Juliane Daartz, Antje-Christin Knopf, Michelle van Heerden, Nicola Bizzocchi, Miriam Varela Vazquez, Barbara Bachtiary, Alessia Pica, Helen A Shih, Damien Charles Weber   +9 more
doaj   +1 more source